Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Real-World Outcomes of Dedicated Leaflet Modification for Bioprosthetic Valve-In-Valve TAVR: A 150-Patient Commercial Experience.

JACC. Cardiovascular interventions·2026

Same author

First-in-Human Mechanical Leaflet Modification of Native Aortic Stenosis During TAVR.

JACC. Case reports·2026

Same author

First-in-Human Transcatheter Aortic Root Tricuspidization of Stenotic Bicuspid Valves: A Strategy to Optimize TAVR.

JACC. Cardiovascular interventions·2026

Same author

Current Evidence, Emerging Evidence, and Decision-Making: An Algorithm for Leaflet Modification Procedures.

JACC. Cardiovascular interventions·2026

Same author

First Large Comprehensive Core-Laboratory Evaluation of Implantation Depth and Clinical Outcomes in TAVR: Final Global Results from the Optimize PRO Prospective Study.

JACC. Cardiovascular interventions·2026

Same author

[Cardiology 2030].

Harefuah·2026

Same journal

Comparing transcatheter aortic valves: time to look beyond simplistic categorisations.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Same journal

Validation of the VARC-HBR consensus for defining high bleeding risk in TAVI.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Same journal

Concomitant transfemoral aortic and mitral valve replacement.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Same journal

AnchorMan versus Watchman 2.5: a randomised comparison in left atrial appendage closure.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Same journal

Prosthesis-patient mismatch with intra-annular self-expanding valves: an analysis of the PORTICO IDE trial.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Same journal

Left atrial appendage closure with the AnchorMan or Watchman devices: 12-month results of the SAFE-PROTECT randomised trial.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 3, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

Residual challenges in TAVI: moving forward.

Marco Barbanti¹, John G Webb, Danny Dvir

¹A.O.U. Policlinico-Vittorio Emanuele, University of Catania, Catania, Italy.

Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

|November 21, 2019

Summary

This summary is machine-generated.

Transcatheter aortic valve implantation (TAVI) is now the leading interventional treatment for aortic stenosis. This review covers TAVI

More Related Videos

Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation

Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation

Published on: June 3, 2018

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

Related Experiment Videos

Last Updated: Jan 3, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation

Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation

Published on: June 3, 2018

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

Area of Science:

Cardiology
Interventional Cardiology
Medical Device Technology

Background:

Transcatheter aortic valve implantation (TAVI) has rapidly evolved over two decades.
It is now the primary interventional approach for aortic stenosis in developed nations.
Continuous advancements in procedural techniques and device engineering characterize its development.

Purpose of the Study:

To provide a comprehensive overview of the dynamic field of TAVI.
To summarize significant historical milestones in TAVI.
To discuss current unresolved challenges in TAVI therapy.

Main Methods:

Literature review of TAVI development and clinical evidence.
Analysis of procedural expertise growth.
Examination of device improvements and their impact.

Main Results:

TAVI has become the dominant treatment for aortic stenosis.
Significant progress has been made in procedural outcomes and device safety.
Extensive research has fueled ongoing optimization of the therapy.

Conclusions:

TAVI represents a major advancement in treating aortic stenosis.
Further research is needed to address remaining challenges and optimize patient outcomes.
The field continues to evolve, promising future improvements in TAVI therapy.